These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 21619948)

  • 1. Genetic background of multiple sclerosis.
    Sadovnick AD
    Autoimmun Rev; 2012 Jan; 11(3):163-6. PubMed ID: 21619948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA-DRB1*15:01 and multiple sclerosis: a female association?
    Irizar H; Muñoz-Culla M; Zuriarrain O; Goyenechea E; Castillo-Triviño T; Prada A; Saenz-Cuesta M; De Juan D; Lopez de Munain A; Olascoaga J; Otaegui D
    Mult Scler; 2012 May; 18(5):569-77. PubMed ID: 22127897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transmission of class I/II multi-locus MHC haplotypes and multiple sclerosis susceptibility: accounting for linkage disequilibrium.
    Chao MJ; Barnardo MC; Lui GZ; Lincoln MR; Ramagopalan SV; Herrera BM; Dyment DA; Sadovnick AD; Ebers GC
    Hum Mol Genet; 2007 Aug; 16(16):1951-8. PubMed ID: 17584771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parent-of-origin effects at the major histocompatibility complex in multiple sclerosis.
    Chao MJ; Herrera BM; Ramagopalan SV; Deluca G; Handunetthi L; Orton SM; Lincoln MR; Sadovnick AD; Ebers GC
    Hum Mol Genet; 2010 Sep; 19(18):3679-89. PubMed ID: 20634196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-DQB1*0602 determines disease susceptibility in a new "humanized" multiple sclerosis model in HLA-DR15 (DRB1*1501;DQB1*0602) transgenic mice.
    Kaushansky N; Altmann DM; Ascough S; David CS; Lassmann H; Ben-Nun A
    J Immunol; 2009 Sep; 183(5):3531-41. PubMed ID: 19648275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential association of vitamin D receptor polymorphism Taq1 with multiple sclerosis.
    Cox MB; Ban M; Bowden NA; Baker A; Scott RJ; Lechner-Scott J
    Mult Scler; 2012 Jan; 18(1):16-22. PubMed ID: 21816760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus and multiple sclerosis: interaction with HLA.
    Sundqvist E; Sundström P; Lindén M; Hedström AK; Aloisi F; Hillert J; Kockum I; Alfredsson L; Olsson T
    Genes Immun; 2012 Jan; 13(1):14-20. PubMed ID: 21776012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complex interactions among MHC haplotypes in multiple sclerosis: susceptibility and resistance.
    Dyment DA; Herrera BM; Cader MZ; Willer CJ; Lincoln MR; Sadovnick AD; Risch N; Ebers GC
    Hum Mol Genet; 2005 Jul; 14(14):2019-26. PubMed ID: 15930013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical, environmental, and genetic determinants of multiple sclerosis in children with acute demyelination: a prospective national cohort study.
    Banwell B; Bar-Or A; Arnold DL; Sadovnick D; Narayanan S; McGowan M; O'Mahony J; Magalhaes S; Hanwell H; Vieth R; Tellier R; Vincent T; Disanto G; Ebers G; Wambera K; Connolly MB; Yager J; Mah JK; Booth F; Sebire G; Callen D; Meaney B; Dilenge ME; Lortie A; Pohl D; Doja A; Venketaswaran S; Levin S; Macdonald EA; Meek D; Wood E; Lowry N; Buckley D; Yim C; Awuku M; Cooper P; Grand'maison F; Baird JB; Bhan V; Marrie RA
    Lancet Neurol; 2011 May; 10(5):436-45. PubMed ID: 21459044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetics in multiple sclerosis susceptibility: difference in transgenerational risk localizes to the major histocompatibility complex.
    Chao MJ; Ramagopalan SV; Herrera BM; Lincoln MR; Dyment DA; Sadovnick AD; Ebers GC
    Hum Mol Genet; 2009 Jan; 18(2):261-6. PubMed ID: 19098025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gender influence in EBV antibody response in multiple sclerosis patients from Kuwait.
    Al-Temaimi R; Alroughani R; Jacob S; Al-Mulla F
    J Neuroimmunol; 2015 Aug; 285():57-61. PubMed ID: 26198919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SNP mapping and candidate gene sequencing in the class I region of the HLA complex: searching for multiple sclerosis susceptibility genes in Tasmanians.
    Burfoot RK; Jensen CJ; Field J; Stankovich J; Varney MD; Johnson LJ; Butzkueven H; Booth D; Bahlo M; Tait BD; Taylor BV; Speed TP; Heard R; Stewart GJ; Foote SJ; Kilpatrick TJ; Rubio JP
    Tissue Antigens; 2008 Jan; 71(1):42-50. PubMed ID: 17971048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis.
    Barcellos LF; Sawcer S; Ramsay PP; Baranzini SE; Thomson G; Briggs F; Cree BC; Begovich AB; Villoslada P; Montalban X; Uccelli A; Savettieri G; Lincoln RR; DeLoa C; Haines JL; Pericak-Vance MA; Compston A; Hauser SL; Oksenberg JR
    Hum Mol Genet; 2006 Sep; 15(18):2813-24. PubMed ID: 16905561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epistasis between HLA-DRB1 parental alleles in a Spanish cohort with multiple sclerosis.
    Romero-Pinel L; Pujal JM; Martínez-Yélamos S; Gubieras L; Matas E; Bau L; Torrabadella M; Azqueta C; Arbizu T
    J Neurol Sci; 2010 Nov; 298(1-2):96-100. PubMed ID: 20810130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic influence of the nonclassical major histocompatibility complex class I molecule MICB in multiple sclerosis susceptibility.
    Fernandez-Morera JL; Rodriguez-Rodero S; Tunon A; Martinez-Borra J; Vidal-Castineira JR; Lopez-Vazquez A; Rodrigo L; Rodrigo P; González S; Lahoz CH; Lopez-Larrea C
    Tissue Antigens; 2008 Jul; 72(1):54-9. PubMed ID: 18588574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome wide differences of gene expression associated with HLA-DRB1 genotype in multiple sclerosis: a pilot study.
    Apperson ML; Tian Y; Stamova B; Ander BP; Jickling GC; Agius MA; Sharp FR
    J Neuroimmunol; 2013 Apr; 257(1-2):90-6. PubMed ID: 23477965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA-patterns in patients with multiple sclerosis and type I diabetes mellitus: evidence for possible mutual exclusion of both diseases.
    Lobnig BM; Chantelau E; Vidgrén G; Van Landeghem AA; Kinnunen L; Tuomilehto-Wolf E
    Diabetes Metab; 2002 Jun; 28(3):217-21. PubMed ID: 12149602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic mechanisms in multiple sclerosis and the major histocompatibility complex (MHC).
    Burrell AM; Handel AE; Ramagopalan SV; Ebers GC; Morahan JM
    Discov Med; 2011 Mar; 11(58):187-96. PubMed ID: 21447278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The nature of genetic and environmental susceptibility to multiple sclerosis.
    Goodin DS; Khankhanian P; Gourraud PA; Vince N
    PLoS One; 2021; 16(3):e0246157. PubMed ID: 33750973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene-environment interactions between HLA B7/A2, EBV antibodies are associated with MRI injury in multiple sclerosis.
    Zivadinov R; Weinstock-Guttman B; Zorzon M; Uxa L; Serafin M; Bosco A; Bratina A; Maggiore C; Grop A; Tommasi MA; Srinivasaraghavan B; Ramanathan M
    J Neuroimmunol; 2009 Apr; 209(1-2):123-30. PubMed ID: 19232441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.